Publications by authors named "Peeter Padrik"

23Publications

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia.

BMC Cancer 2020 Mar 12;20(1):201. Epub 2020 Mar 12.

Tartu University Hospital, Clinic of Hematology & Oncology, Puusepa 8, Tartu, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-020-6685-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068934PMC
March 2020

Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.

BMC Cancer 2019 Jun 10;19(1):557. Epub 2019 Jun 10.

Estonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, 51010, Tartu, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5783-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558751PMC
June 2019

A dual colour FISH method for routine validation of sexed Bos taurus semen.

BMC Vet Res 2019 Apr 3;15(1):104. Epub 2019 Apr 3.

Institute of Molecular and Cell Biology, University of Tartu, Riia 23, 51010, Tartu, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12917-019-1839-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446427PMC
April 2019

Increasing kidney cancer incidence and survival in Estonia: role of age and stage.

Acta Oncol 2019 Jan 3;58(1):21-28. Epub 2018 Oct 3.

a Department of Epidemiology and Biostatistics , National Institute for Health Development , Tallinn , Estonia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/0284186X.2018.1
Publisher Site
http://dx.doi.org/10.1080/0284186X.2018.1512158DOI Listing
January 2019

Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study.

Acta Oncol 2017 Jan 31;56(1):52-58. Epub 2016 Oct 31.

c Department of Epidemiology and Biostatistics , National Institute for Health Development , Tallinn , Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2016.1243804DOI Listing
January 2017

Mammography use and mode of detection among breast cancer patients in Estonia.

Women Health 2016 1;56(2):129-40. Epub 2015 Sep 1.

a Department of Epidemiology and Biostatistics , National Institute for Health Development , Tallinn , Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03630242.2015.1086468DOI Listing
July 2016

Sex differences in cancer survival in Estonia: a population-based study.

BMC Cancer 2015 Feb 19;15:72. Epub 2015 Feb 19.

Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1080-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336752PMC
February 2015

Bovine sperm plasma membrane proteomics through biotinylation and subcellular enrichment.

Proteomics 2015 Jun 21;15(11):1906-20. Epub 2015 Mar 21.

Competence Centre on Reproductive Medicine and Biology, Tartu, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.201400297DOI Listing
June 2015

Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia.

BMC Public Health 2013 Oct 9;13:947. Epub 2013 Oct 9.

Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2458-13-947DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852399PMC
October 2013

Time trends in population-based breast cancer survival in Estonia: analysis by age and stage.

Acta Oncol 2014 Feb 14;53(2):226-34. Epub 2013 Jun 14.

Department of Epidemiology and Biostatistics, National Institute for Health Development , Tallinn , Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2013.806992DOI Listing
February 2014

Time-gated luminescence assay using nonmetal probes for determination of protein kinase activity-based disease markers.

Anal Biochem 2012 Mar 8;422(2):79-88. Epub 2012 Jan 8.

Institute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ab.2011.12.048DOI Listing
March 2012

Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.

Expert Opin Pharmacother 2012 Feb 23;13(2):159-74. Epub 2011 Dec 23.

Department of Oncology, University Hospital Split, Split, Spinciceva 1, 21000 Split, Croatia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2012.647406DOI Listing
February 2012

Thymidine phosphorylase as a prognostic factor in renal cell carcinoma.

Int Urol Nephrol 2010 Jun 2;42(2):295-8. Epub 2009 Jul 2.

Clinic of Hematology & Oncology, Tartu University Hospital, Puusepa 8, Tartu, 51014, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-009-9603-4DOI Listing
June 2010

Changes in the natural history of renal cancer: comparison of Estonian data from the periods 1986-1988 and 1996-1998.

Int Urol Nephrol 2007 25;39(1):35-41. Epub 2006 Oct 25.

Clinic of Hematology & Oncology, Tartu University Hospital, Vallikraavi 7, Tartu 51003, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-006-9110-9DOI Listing
November 2007

The effects of ovarian function on estrus synchronization with PGF in dairy cows.

Theriogenology 2006 Sep 11;66(5):1364-74. Epub 2006 Jul 11.

Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences, 62 Kreutzwaldi St., 51014 Tartu, Estonia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0093691X0600277
Publisher Site
http://dx.doi.org/10.1016/j.theriogenology.2006.04.030DOI Listing
September 2006

Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: a phase II study.

Urol Oncol 2004 Sep-Oct;22(5):387-92

Clinic of Hematology & Oncology, Tartu University Clinics, Vallikraavi 7, Tartu, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2003.11.014DOI Listing
January 2005

Prognostic factors of immunotherapy in metastatic renal cell carcinoma.

Authors:
Peeter Padrik

Med Oncol 2003 ;20(4):325-34

Clinic of Hematology & Oncology, Tartu University Clinics, Vallikraavi 7, Tartu, 51003 ESTONIA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/MO:20:4:325DOI Listing
January 2004